Skip to content

Aurinia Pharmaceuticals

US · AUPH #2749 by market cap Listed 1970
16.01 +0.32 +2.04%
Live - 5344 symbols - heartbeat 358s ago · 2026-10-08 04:00
Pre-market 16.01 0.00%
After-hours 16.01 0.00%
Market cap
2.13B
P/B
3.46
EPS
2.07
Reader sentiment Are you bullish or bearish on AUPH?

Anonymous reader poll. Unscientific, not investment advice.

Shares of Aurinia Pharmaceuticals closed at 16.01, up 2.04%. At current prices, the business is worth about 2.13B, the #2749 most valuable US-listed company we track. The trailing P/E of 6.88 is 216% above its five-year average of 2.18. Wall Street's 2-analyst consensus lands on Buy, with a price target averaging 19.00 (+19% from here). Against a 52-week band of 10.90-19.25, the shares are currently 61% of the way up.

✦ StockVane Quant Insights how this is computed

Quant Rating B Buy
  • Twelve-month momentum in the top 21% of the universe, above its 200-day average.
  • Signal has read BUY for 1 week.
  • Its last 5 Buy calls have averaged +11% over the following quarter.
See the full rating history & follow-along return →
Quant Sentiment Bullish
  • Recent price momentum is +17.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 6.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

18.6214.5716.012026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -1.14%
1M -0.44%
3M -1.29%
6M +1.39%
YTD +0.38%
1Y +36.72%
3Y +119.32%
5Y -19.30%

Key statistics

Price & volume

Prev close
15.69
Open
15.56
Day range
15.50 - 16.16
Avg price
15.98
Volume
682.53K
Turnover
10.91M
Amplitude
4.21%
52-week range
10.90 - 19.25

Valuation

P/E
7.73
P/E (TTM)
7.02
P/B
3.46
EPS
2.07
Net profit
275.42M
Net assets
614.83M

Share structure

Market cap
2.13B
Float cap
2.07B
Shares out
133.05M
Float shares
129.22M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 61% of range
10.90 19.25

16.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-1.71M net over the window

Short interest

Shares short
8.58M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Aurinia Pharmaceuticals (AUPH)?

Aurinia Pharmaceuticals last traded at 16.01. The quote on this page refreshes every few seconds while US markets are open.

What is Aurinia Pharmaceuticals's market cap?

About 2.13B.

What is the P/E ratio of Aurinia Pharmaceuticals?

The trailing twelve-month P/E is 7.02, above its own 5-year average of 2.18 — toward the top of its historical range (69.30% percentile). See the Valuation tab for the full history.

Does Aurinia Pharmaceuticals pay a dividend?

Aurinia Pharmaceuticals does not currently pay a regular dividend.

Is Aurinia Pharmaceuticals a buy according to analysts?

The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 19.00, which implies 18.7% upside from the current price. This is not investment advice.

What is Aurinia Pharmaceuticals's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Aurinia Pharmaceuticals a B (Buy). Twelve-month momentum in the top 21% of the universe, above its 200-day average. Not investment advice.

Quote time 2026-10-08 04:00:03 · For reference only, not investment advice and not tailored to your situation.